6915-3 Opioid Use Disorder; Grand Rounds Inspira Health Network-Recording

Video Transcription

Video Summary

In this grand rounds presentation, Dr. Schulman discussed the topic of opioid use disorder, highlighting his research focus on clinical trials and the use of technology to enhance treatment delivery. He emphasized the importance of medication for opioid use disorder, including methadone, buprenorphine, and naltrexone, and shared insights from trials comparing these medications. Dr. Schulman also addressed common misconceptions about these medications, such as the use of methadone and its impact on dental health. Additionally, he touched on the changes in legislation allowing more healthcare providers to prescribe buprenorphine without the X-waiver requirement. The discussion also covered the intersection of 12-step programs and medication for opioid use disorder, acknowledging potential conflicts and strategies for addressing them with patients. Attendees were encouraged to participate in providing feedback and obtaining CME credits.

Keywords

opioid use disorder

clinical trials

technology

medication

methadone

buprenorphine

naltrexone

legislation

12-step programs